HLS.AX Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 08:10):

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others...

Stats
Tagesvolumen	6.40M
Durchschnittsvolumen	2.80M
Marktkapitalisierung	798.71M
EPS	$0 ( 2024-02-26 )
Last Dividend	$0.0600 ( 2022-09-07 )
Next Dividend	$0 ( N/A )
P/E	-0.670
ATR14	$0.00100 (0.09%)

Volumen Korrelation

Lang: -0.12 (neutral)

Kurz: -0.02 (neutral)

Signal:(71.231) Neutral

Healius Ltd Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Healius Ltd Korrelation - Währung/Rohstoff

0.00
( neutral )

0.42
( neutral )

0.00
( neutral )

0.55
( weak )

Healius Ltd Finanzdaten

Annual	2023
Umsatz:	$1.71B
Bruttogewinn:	$341.70M (20.02 %)
EPS:	$-0.630

FY	2023
Umsatz:	$1.71B
Bruttogewinn:	$341.70M (20.02 %)
EPS:	$-0.630

FY	2022
Umsatz:	$2.34B
Bruttogewinn:	$2.02B (86.44 %)
EPS:	$0.530

FY	2021
Umsatz:	$1.90B
Bruttogewinn:	$1.63B (85.76 %)
EPS:	$0.0702

Financial Reports:

No articles found.

Healius Ltd Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0600 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Healius Ltd Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 1.719 - low (50.00%) | Divividend Growth Potential Score: 1.361 - No dividend growth expected in the near future

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0237	1999-04-12
Last Dividend	$0.0600	2022-09-07
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	47	--
Total Paid Out	$3.43	--
Avg. Dividend % Per Year	0.00%	--
Score	1.43	--
Div. Sustainability Score	1.719
Div.Growth Potential Score	1.361
Div. Directional Score	1.540	--

Next Divdend (Est)
(2024-06-24)

$0 Estimate 0.00 %

Dividend Stability

0.10 Very Bad

Dividend Score

1.43

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for ASX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
LSF.AX	Ex Dividend Junior	2023-09-11	Semi-Annually	0.00%
TAH.AX	Ex Dividend Junior	2023-08-31	Annually	0.00%
CSR.AX	Ex Dividend Knight	2023-05-26	Annually	0.00%
NCM.AX	Ex Dividend Knight	2023-10-18	Semi-Annually	0.00%
WPR.AX	Ex Dividend Junior	2023-06-29	Quarterly	0.00%
FAR.AX	No Dividend Player	2023-08-23	Sporadic	0.00%
PL8.AX	Ex Dividend Knight	2023-09-14	Monthly	0.00%
APE.AX	Ex Dividend Junior	2023-09-01	Annually	0.00%
HZN.AX	Ex Dividend Knight	2023-10-17	Annually	0.00%
RWC.AX	Ex Dividend Knight	2023-09-07	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.580	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.325	1.200	-10.00	-10.00	[0 - 0.3]
returnOnEquityTTM	-0.768	1.500	-9.64	-10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.527	0.800	-2.36	-1.890	[1 - 3]
quickRatioTTM	0.471	0.800	-1.934	-1.547	[0.8 - 2.5]
cashRatioTTM	0.144	1.500	-0.313	-0.470	[0.2 - 2]
debtRatioTTM	0.224	-1.500	6.27	-9.40	[0 - 0.6]
interestCoverageTTM	1.020	1.000	-0.733	-0.733	[3 - 30]
operatingCashFlowPerShareTTM	0.428	2.00	9.86	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.314	2.00	9.84	10.00	[0 - 20]
debtEquityRatioTTM	0.644	-1.500	7.43	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.185	1.000	-0.246	-0.246	[0.2 - 0.8]
operatingProfitMarginTTM	0.0421	1.000	-1.158	-1.158	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.376	1.000	9.02	9.02	[0.2 - 2]
assetTurnoverTTM	0.561	0.800	9.59	7.68	[0.5 - 2]
Total Score				1.719

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.663	1.000	-0.168	0	[1 - 100]
returnOnEquityTTM	-0.768	2.50	-6.20	-10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.314	2.00	9.90	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.428	2.00	9.86	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00280	1.500	-3.31	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.150	1.000	8.75	0	[0.1 - 0.5]
Total Score				1.361

Healius Ltd

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.